Clinical trial
Role of Exenatide in Type 1 Diabetes
NCT00456300 · Montefiore Medical Center, Other · Completed
Key facts
| NCT number | NCT00456300 |
|---|---|
| Title | Role of Exenatide in Type 1 Diabetes |
| Official title | The Role of Exenatide in Type 1 Diabetes Mellitus |
| Lead sponsor | Montefiore Medical Center, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | Exenatide, Insulin |
| Enrollment | 11 |
| Start date | Mar 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Apr 4, 2007 |
| Last update posted | Feb 26, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: